Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Semmes

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
JCI Insight|July 6, 2021
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescentsCarolina Garrido, Jillian H Hurst, Cynthia G Lorang, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2023
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasisSantanu Maji, Anjan K Pradhan, Amit Kumar, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Clinical Chemistry|December 23, 2004
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes, Ziding Feng, Bao-Ling Adam, et al.
Nature Structural & Molecular Biology|April 1, 2026
Resolution of R-loops and transcription-replication conflicts by SETX-BRCA1-BARD1 complexArijit Dutta, Jae-Hoon Ji, Shahrez Syed, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
JCI Insight|July 6, 2021
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescentsCarolina Garrido, Jillian H Hurst, Cynthia G Lorang, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2023
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasisSantanu Maji, Anjan K Pradhan, Amit Kumar, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Clinical Chemistry|December 23, 2004
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes, Ziding Feng, Bao-Ling Adam, et al.
Nature Structural & Molecular Biology|April 1, 2026
Resolution of R-loops and transcription-replication conflicts by SETX-BRCA1-BARD1 complexArijit Dutta, Jae-Hoon Ji, Shahrez Syed, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Pageof 23